Baton Rouge Investor Collective

It’s time to cast your vote! As a member of the Investor Collective, you have the ability to designate how the group’s funds will support the Cancer Center’s mission over the next year. Voting begins Monday, May 6 and ends Friday, May 10 at 12 p.m.

We are proud to present three mission-critical programs that are vying for the Collective’s support. You can choose a specific program or vote for all three.

Clinical Research

Research is the key to the future of cancer care. By championing clinical research at Mary Bird Perkins, we pave the way for groundbreaking advancements in cancer treatment, significantly improving patient outcomes and survival rates in Louisiana. This focus on clinical research, bolstered by philanthropic support, is vital for integrating cutting-edge therapies into overall cancer care, making innovative treatments accessible close to home. Fueled by the brightest minds and the support of our community, our commitment to this research aims to establish the state’s leading clinical research program.

Dental Oncology Program

Mary Bird Perkins’ Dental Oncology Program addresses a critical, often overlooked aspect of cancer care, particularly for patients with head and neck cancers. These patients frequently require dental extractions before initiating radiation therapy to mitigate the risk of severe bone damage. However, a significant challenge arises due to socioeconomic barriers faced by many of these patients, who are often underinsured or uninsured.

Through financial support from donors, we offer comprehensive dental services at a discounted rate, provided by specialized oncologic dentists and dental surgery providers. This programmatic support is crucial for reducing delays in cancer care and minimizing the risk of late-term effects associated with treatment. By addressing this vital component of cancer care, we are committed to improving our patients’ health and quality of life during their healing journey.

Scale the Mission 

Mary Bird Perkins is broadening its impact, expanding access to quality care to more patients and families across the region. This critical funding will be prioritized to advancing our mission in underserved rural areas across all pillars of philanthropy, including prevention, early detection, expert treatment, cutting-edge technology, and comprehensive survivorship programs. This approach ensures that both patients and physicians are equipped with the essential resources necessary to enhance outcomes, affirming our commitment to delivering the highest level of care and support to communities far and wide.